Gland Pharma Q3 Results: Profit surges 28% YoY to ₹261 crore; revenue rises 22%
Gland Pharma reported a 27.74% increase in Q3 net profit to ₹261.48 crore, up from ₹204.69 crore last year. Revenue rose 22.49% YoY to ₹1695.36 crore, with EBITDA increasing 21% YoY to ₹434.9 crore.
Gland Pharma reported a 27.74% increase in Q3 net profit to ₹261.48 crore, up from ₹204.69 crore last year. Revenue rose 22.49% YoY to ₹1695.36 crore, with EBITDA increasing 21% YoY to ₹434.9 crore.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
